BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19901560)

  • 1. Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy.
    Yuk JM; Shin DM; Song KS; Lim K; Kim KH; Lee SH; Kim JM; Lee JS; Paik TH; Kim JS; Jo EK
    Autophagy; 2010 Jan; 6(1):46-60. PubMed ID: 19901560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.
    Tsuji S; Matsumoto M; Takeuchi O; Akira S; Azuma I; Hayashi A; Toyoshima K; Seya T
    Infect Immun; 2000 Dec; 68(12):6883-90. PubMed ID: 11083809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-Encapsulated Bacillus Calmette-Guérin Cell Wall Skeleton Enhances Antitumor Efficiency for Bladder Cancer In Vitro and In Vivo via Induction of AMP-Activated Protein Kinase.
    Whang YM; Yoon DH; Hwang GY; Yoon H; Park SI; Choi YW; Chang IH
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33302414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
    Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
    BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer.
    Shibata T; Takata E; Sakamoto J; Shioya A; Yamada S; Takakura M; Sasagawa T
    Medicine (Baltimore); 2022 Dec; 101(52):e32481. PubMed ID: 36595982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
    Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
    Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus Calmette-Guérin cell-wall skeleton enhances the killing activity of cytotoxic lymphocyte-activated human dendritic cells transduced with the prostate-specific antigen gene.
    Fujii R; Iwahashi M; Kikkawa K; Inagaki T; Kohjimoto Y; Ojima T; Mori T; Kuramoto T; Nishizawa S; Azuma I; Yamaue H; Shinka T; Hara I
    BJU Int; 2009 Dec; 104(11):1766-73. PubMed ID: 20063450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro.
    Kato T; Bilim V; Yuuki K; Naito S; Yamanobe T; Nagaoka A; Yano I; Akaza H; Tomita Y
    Anticancer Res; 2010 Oct; 30(10):4089-96. PubMed ID: 21036724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
    Pal I; Dey KK; Chaurasia M; Parida S; Das S; Rajesh Y; Sharma K; Chowdhury T; Mandal M
    Tumour Biol; 2016 May; 37(5):6389-402. PubMed ID: 26631035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.
    Masuda H; Nakamura T; Noma Y; Harashima H
    Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
    Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
    Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acriflavine enhances radiosensitivity of colon cancer cells through endoplasmic reticulum stress-mediated apoptosis.
    Lim MJ; Ahn JY; Han Y; Yu CH; Kim MH; Lee SL; Lim DS; Song JY
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1214-22. PubMed ID: 22564437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages.
    Begum NA; Ishii K; Kurita-Taniguchi M; Tanabe M; Kobayashi M; Moriwaki Y; Matsumoto M; Fukumori Y; Azuma I; Toyoshima K; Seya T
    Infect Immun; 2004 Feb; 72(2):937-48. PubMed ID: 14742539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
    Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
    Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model.
    Nakamura T; Fukiage M; Suzuki Y; Yano I; Miyazaki J; Nishiyama H; Akaza H; Harashima H
    J Control Release; 2014 Dec; 196():161-7. PubMed ID: 25315488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
    Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
    Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticulation of BCG-CWS for application to bladder cancer therapy.
    Nakamura T; Fukiage M; Higuchi M; Nakaya A; Yano I; Miyazaki J; Nishiyama H; Akaza H; Ito T; Hosokawa H; Nakayama T; Harashima H
    J Control Release; 2014 Feb; 176():44-53. PubMed ID: 24389133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
    Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T
    Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells.
    Alotaibi M; Sharma K; Saleh T; Povirk LF; Hendrickson EA; Gewirtz DA
    Radiat Res; 2016 Mar; 185(3):229-45. PubMed ID: 26934368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on antitumor effect of cell-wall skeleton of Mycobacterium bovis BCG and Nocardia rubra, with reference to T-cell dependency and independency.
    Yanagawa E; Yasumoto K; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Gan; 1979 Apr; 70(2):141-6. PubMed ID: 381087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.